The expression of PARK7 is upregulated in 85% of glioblastoma tissues and is strongly associated with the nuclear expression of TP53, which in turn is associated with mutations in TP53 and other abnormal perturbations of the TP53 pathway. Here, TP53 is linked to glioblastoma.